Sema4 (NASDAQ:SMFR) Hits New 12-Month Low at $3.91

Sema4 Holdings Corp (NASDAQ:SMFR)’s stock price reached a new 52-week low during trading on Friday . The company traded as low as $3.91 and last traded at $3.93, with a volume of 18000 shares trading hands. The stock had previously closed at $4.03.

SMFR has been the topic of a number of analyst reports. Zacks Investment Research cut Sema4 from a “hold” rating to a “sell” rating in a research report on Thursday, November 25th. BTIG Research initiated coverage on Sema4 in a research report on Friday, October 8th. They set a “buy” rating and a $12.00 target price on the stock. Jefferies Financial Group started coverage on Sema4 in a research report on Friday, September 24th. They set a “buy” rating and a $13.00 target price on the stock. Cowen started coverage on Sema4 in a report on Thursday, September 30th. They issued an “outperform” rating and a $13.00 price objective on the stock. Finally, The Goldman Sachs Group started coverage on Sema4 in a report on Friday, November 19th. They issued a “buy” rating and a $12.00 price objective on the stock. One investment analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Sema4 presently has an average rating of “Buy” and an average target price of $12.50.

The company has a debt-to-equity ratio of 0.03, a current ratio of 7.55 and a quick ratio of 7.11. The stock has a fifty day moving average price of $5.73.

Sema4 (NASDAQ:SMFR) last posted its quarterly earnings data on Monday, November 15th. The company reported $0.15 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.19) by $0.34. The firm had revenue of $43.18 million during the quarter, compared to analyst estimates of $42.00 million. On average, research analysts expect that Sema4 Holdings Corp will post -0.73 EPS for the current year.

In other Sema4 news, COO James Coffin sold 5,752 shares of the firm’s stock in a transaction that occurred on Monday, October 25th. The shares were sold at an average price of $7.54, for a total value of $43,370.08. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Isaac Ro sold 19,516 shares of the firm’s stock in a transaction that occurred on Monday, November 8th. The stock was sold at an average price of $8.49, for a total transaction of $165,690.84. The disclosure for this sale can be found here. Insiders sold a total of 117,553 shares of company stock worth $895,784 over the last three months.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Royal Bank of Canada purchased a new stake in shares of Sema4 during the 3rd quarter valued at approximately $36,000. Citigroup Inc. purchased a new stake in shares of Sema4 during the 3rd quarter valued at approximately $79,000. Victory Capital Management Inc. purchased a new stake in shares of Sema4 during the 3rd quarter valued at approximately $88,000. Clearwater Capital Advisors LLC purchased a new stake in shares of Sema4 during the 3rd quarter valued at approximately $93,000. Finally, Tudor Investment Corp Et Al purchased a new stake in shares of Sema4 during the 3rd quarter valued at approximately $106,000.

Sema4 Company Profile (NASDAQ:SMFR)

Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Sema4 Holdings Corp, formerly known as CM Life Sciences, is based in STAMFORD, Conn.

Featured Article: CD Ladder

Receive News & Ratings for Sema4 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sema4 and related companies with MarketBeat.com's FREE daily email newsletter.